Vigabatrin Tablet, Film Coated
Product Images NDC 43598-651

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 43598-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Vigabatrin Tablets, USP 500 mg, a film-coated oral tablet by Dr. Reddy's Laboratories Inc. The label includes the NDC 43598-651-01, storage instructions at 20°C to 25°C, dispensing instructions, quantity of 100 tablets, and a barcode. It states the active ingredient is vigabatrin, 500 mg per tablet.*

FDA Label Image

Figure1 (Figure1)

A cumulative distribution plot showing percentage reduction in seizure frequency versus percentage of patients for different dosages of Vigabatrin (1g/day, 3g/day, 6g/day) compared to placebo. The vertical axis represents percent reduction in seizure frequency with improvement above zero and worsening below zero. The horizontal axis represents percent of patients. Multiple dose-response curves are displayed, illustrating seizure frequency changes across patient groups.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the percentage reduction in seizure frequency on the y-axis versus the percentage of patients on the x-axis. Two lines compare outcomes for Placebo and 3 g/day Vigabatrin (VGB). The y-axis includes labels indicating improvement, no change, and worsening in seizure frequency.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Vigabatrin, showing its molecular arrangement including an amino group, carbon chain, and carboxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.